Filter Results :

Your search for Pharmaceutical returned 23911 reports

Sort by


Global Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Pharmaceutical companies will face an increasing number of external risks to their operations. Many of these new challenges emanate from the global financial crisis of 2007/08. In an era of fiscal pressures, governments are seeking to control growth in healthcare spending and will...

$ 1,295.00

Read More

Philippines Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The Philippine pharmaceutical market is relatively small considering its large population and disease burden. Low government spending on healthcare, which falls below the WHO's global standards, and low-income levels limit opportunities for innovative drugmakers. The expansion of ...

$ 1,295.00

Read More

Taiwan Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Cross-strait relations will be an important factor influencing the prospects of Taiwan's pharmaceutical industry. The country's medicine exports to China have grown substantially and now account for 14% of the total value, ahead of its exports to Japan and South Korea. Growth pros...

$ 1,295.00

Read More

Netherlands Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The Netherlands has a well establish pharmaceutical and healthcare sector. In 2016, the pharmaceutical market will face yet another year of contraction in value terms before returning to growth in 2017. Medicine sales will be driven by an ageing population and high per capita spen...

$ 1,295.00

Read More

Poland Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Poland will remain one of the most attractive pharmaceutical and healthcare markets in the CEE region. Strong economic growth and the introduction of a tax-funded healthcare system will support strong market growth. Opportunities for innovative drugmakers will be significant, with...

$ 1,295.00

Read More

Iran Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The Iranian government is looking to attract greater direct investment by leveraging the growing interest of multinational pharmaceutical companies interested in exploring the high-growth potential of Iran's pharmaceutical market in the post-sanctions period. However, given underl...

$ 1,295.00

Read More

Israel Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Israel will continue to be targeted by multinational drugmakers as a destination for innovative drug sales; however, their relative success will be limited by funding constraints towards the country's health services basket and the lack of transparency with new drug inclusions. An...

$ 1,295.00

Read More

United Kingdom Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The rate of investment in pharmaceutical and biomedicine R&D in the UK will remain significantly high. Meanwhile, our earlier view on upside risks to healthcare spending has started to materialise, with the latest data leading us to revise upwards the UK healthcare market fore...

$ 1,295.00

Read More

Ukraine Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Wide-scale changes to the regulatory environment of Ukraine's pharmaceutical sector will increase its attractiveness to multinational pharmaceutical manufactures. The introduction of reference pricing will aid in improving medicine affordability and accessibility, driving increase...

$ 1,295.00

Read More

Mexico Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The government's efforts to improve competitiveness in Mexico's pharmaceutical sector combined with the country's economic outperformance compared with large countries like Brazil will improve Mexico's attractiveness to drugmakers. Headline Expenditure Projections -Pharmace...

$ 1,295.00

Read More

Industrial Cooling System Market by End User (Power Generation, Industrial Manufacturing, Petrochemical Processing, Food Processing & Storage, Petroleum & Natural Gas Refining, Pharmaceutical, Data Center), Type & by Region - Global Forecasts to 2021

12 Jul 2016  |  Published by:  MarketsandMarkets
“The global industrial cooling system market is projected to grow at a CAGR of 5.0% from 2016 to 2021” The global industrial cooling system market is projected to reach USD 17.24 billion by 2021, at a CAGR of 5.0% between 2016 and 2021. Stringent environment regulations for industrial cooli...

$ 5,650.00

Read More

U.S. Pharmaceutical Preparation Market. Analysis And Forecast to 2020

08 Jul 2016  |  Published by:  IndexBox Marketing Ltd.
The report provides an in-depth analysis of the U.S. Pharmaceutical Preparation market. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the ...

$ 1,635.51

Read More

Succinic Acid Market by Type (Bio-based, Petro-based), Application (Polyurethane, Resins, Coatings & Pigments, Pharmaceuticals, Plasticizers, Food & Beverage, PBS/PBST, Solvents & Lubricants, De-Icer Solutions, Personal Care, and Others), and by Region - Global Forecast to 2021

08 Jul 2016  |  Published by:  MarketsandMarkets
Increasing demand from polyurethanes, plastics, and food packaging driving the global succinic acid market The global succinic acid market is projected to reach USD 701.0 million by 2021, registering a CAGR of 28.0% from 2016 to 2021. The market is projected to register a CAGR of 27.2% from...

$ 5,650.00

Read More

Norway Pharmaceuticals and Healthcare Report

06 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Norway's life sciences and biomedical research base will continue to develop at a sustained pace, which will enhance investment opportunities over the medium to long term. Meanwhile, Norway's ongoing expansionary fiscal policy, as well as market growth fundamentals, will underpin ...

$ 1,295.00

Read More

Sub-Saharan Africa Pharmaceuticals and Healthcare Report

06 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Sub-Saharan Africa's pharmaceutical market will continue to provide revenue-earning opportunities for multinational pharmaceutical companies. Cost-containment initiatives will be widespread, however, limiting patented drug sales growth but boosting commercial opportunities within ...

$ 1,295.00

Read More
Total 23911 records.